| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/15/2014 | EP2683420A1 Improvements to immobilised biological entities |
| 01/15/2014 | EP2683410A2 Targeted nanocarrier systems for delivery of actives across biological membranes |
| 01/15/2014 | EP2683409A1 Amatoxin-conjugates with improved linkages |
| 01/15/2014 | EP2683408A1 Conjugation process |
| 01/15/2014 | EP2683407A1 Thermo-responsive hydrogel compositions |
| 01/15/2014 | EP2683403A1 Non-aqueous high concentration reduced viscosity suspension formulations of antibodies |
| 01/15/2014 | EP2683386A2 Compounds and methods of use in ablative radiotherapy |
| 01/15/2014 | EP2683376A2 Methods for treating diseases using isoindoline compounds |
| 01/15/2014 | EP2683375A1 Colonoscopy - preparation |
| 01/15/2014 | EP2683365A1 Pharmaceutical formulation for producing rapidly disintegrating tablets |
| 01/15/2014 | EP2683362A2 Protein nanoparticle dispersions |
| 01/15/2014 | EP2683360A1 Pegylated apelin and uses thereof |
| 01/15/2014 | EP2403477B1 Cationic oil-in-water emulsions containing prostaglandins and uses thereof |
| 01/15/2014 | EP2309990B1 Drug loaded polymeric nanoparticles and methods of making and using same |
| 01/15/2014 | CN103517719A Antibody-drug conjugates |
| 01/15/2014 | CN103517716A Tolerogenic synthetic nanocarriers for inducing regulatory b cells |
| 01/15/2014 | CN103517708A Pharmaceutical composition |
| 01/15/2014 | CN103517707A Controlled release of immunosuppressants from synthetic nanocarriers |
| 01/15/2014 | CN103509183A Degradable gene vector based on polyethyleneimine and preparation method thereof |
| 01/15/2014 | CN103509121A FSH (follicle-stimulating hormone) fusion protein, and preparation method and application thereof |
| 01/15/2014 | CN103509119A Recombinant fusion protein of short peptide hormone and recombinant pseudomonas exotoxin A and application thereof |
| 01/15/2014 | CN103509118A Insulin-Fc fusion protein |
| 01/15/2014 | CN103509066A Lipid derivative containing sialic acid fragment and application thereof |
| 01/15/2014 | CN103505744A Gene delivery system of targeting brain capillary endothelial cell |
| 01/15/2014 | CN103505741A Tegafur-layered double-metal hydroxide nanometer hybrid modified with polyethylene glycol derivative on surface and preparation of nanometer hybrid |
| 01/15/2014 | CN103505740A Cyclodextrin mifepristone clathrate compound, preparation method thereof, and pharmaceutical composition containing clathrate compound |
| 01/15/2014 | CN103505739A Method for preparing antitumor drug carrier by using rolling circle amplification technology |
| 01/15/2014 | CN103505738A Preparation of acrylic copolymer composite albumin nanoparticles and application thereof as drug carriers |
| 01/15/2014 | CN103505737A Method for preparing docetaxel/beta-cyclodextrin clathrates |
| 01/15/2014 | CN103505736A Modified hyaluronic acid based macromolecule lipidosome and preparation method thereof |
| 01/15/2014 | CN103505733A Oral liquid preparation with macrolides medicine as active component |
| 01/15/2014 | CN103505730A Copper selenide/mesoporous silica core-shell nanoparticles and preparation method and application thereof |
| 01/15/2014 | CN103505723A Method for preparing freeze-dried rabies vaccine preparation |
| 01/15/2014 | CN103505722A Application of interferon in treating/preventing tumors with resistance to conventional antineoplastic therapies, and related product and method |
| 01/15/2014 | CN103505474A Preparation of donkey-hide gelatin effervescent tablet |
| 01/15/2014 | CN103505471A Dairy cow nipple antifreezing disinfector and preparation method thereof |
| 01/15/2014 | CN103505466A Solid compound preparation containing metformin hydrochloride and glimepiride, preparation method and application thereof |
| 01/15/2014 | CN103505459A Pharmaceutical composition of linezolid |
| 01/15/2014 | CN103505453A Orlistat oral solid preparation and preparation method thereof |
| 01/15/2014 | CN103505447A Ibuprofen-containing pharmaceutical composition and its use |
| 01/15/2014 | CN103505446A Pharmaceutical composition and its use |
| 01/15/2014 | CN103505442A Target nano lipid core micelle used for carrying docetaxel, and preparation method and applications thereof |
| 01/15/2014 | CN103505440A Stable azelnidipine capsule |
| 01/15/2014 | CN103505439A Mitiglinide calcium capsules |
| 01/15/2014 | CN103505438A Calcium dobesilate capsules |
| 01/15/2014 | CN103505437A Stable pitavastatin calcium capsules |
| 01/15/2014 | CN103505436A Preparation method of lansoprazole capsule |
| 01/15/2014 | CN103505434A Cefuroxime axetil tablet and preparation method thereof |
| 01/15/2014 | CN103505433A Method of preparing composite granule comprising low-substituted hydroxypropyl cellulose and rapid release preparation |
| 01/15/2014 | CN103505432A Stable mitiglinide calcium tablets |
| 01/15/2014 | CN103505431A Repaglinide tablets |
| 01/15/2014 | CN103505430A Cefixime tablets |
| 01/15/2014 | CN103505429A Gliguidone tablet |
| 01/15/2014 | CN103505428A Glipizide sugar-free tablet |
| 01/15/2014 | CN103505427A Agomelatine tablet |
| 01/15/2014 | CN103505426A Stable azelnidipine tablet |
| 01/15/2014 | CN103505425A Stable pitavastatin calcium tablets |
| 01/15/2014 | CN103505424A Preparation method for bortezomib for injection |
| 01/15/2014 | CN103505423A Bromhexine hydrochloride freeze-dried powder injection and preparation method thereof |
| 01/15/2014 | CN103505422A Solubilized emodin drug-loaded pellet core, colon-targeted pellet and preparation method thereof |
| 01/15/2014 | CN103505419A Oxygen-carrying lipidosome with low surface tension and preparation method thereof |
| 01/15/2014 | CN103505411A Ornidazole injection |
| 01/15/2014 | CN103505409A 3-n-butylphthalide injection and preparation method thereof |
| 01/15/2014 | CN103505408A Preparation method of oxiracetam glucose/sodium chloride injection |
| 01/15/2014 | CN103505407A Multi-chamber bag packaged moxifloxacin hydrochloride/glucose aqueous solution preparation |
| 01/15/2014 | CN103505405A Aquagel composition and application composed of same |
| 01/15/2014 | CN103505404A Oral liquid preparation with roxithromycin as active component |
| 01/15/2014 | CN103041322B Pinellia ternate heart-fire removing dropping pill and preparation method thereof |
| 01/15/2014 | CN103007292B MiR-3OB (Micro-Ribonucleic Acid-30b) composite for targeting microglia as well as preparation method and application of composite |
| 01/15/2014 | CN102886048B Building method for medicament transportation or radiography carrier containing coat protein and inorganic nanoparticles |
| 01/15/2014 | CN102885785B Adriamycin-containing nanometer medicament microspheres and preparation method thereof |
| 01/15/2014 | CN102846544B Self-microemulsion composition of insoluble medicine |
| 01/15/2014 | CN102772381B Fasudil-contained pharmaceutical composition |
| 01/15/2014 | CN102716098B Cefditoren pivoxil liposome solid preparation |
| 01/15/2014 | CN102716082B Cefoxitin sodium liposome injection |
| 01/15/2014 | CN102697720B Irinotecan hydrochloride lipid nanoparticles injection |
| 01/15/2014 | CN102603866B Oligopeptide-based pH-sensitive amphoteric ion and application thereof in medicament |
| 01/15/2014 | CN102585303B Chitosan/polylysine in-situ gel and preparation method thereof |
| 01/15/2014 | CN102579348B Fosinopril sodium liposome solid preparation |
| 01/15/2014 | CN102558535B Amphiphilic block copolymer connected through molecular glue and synthesis method and application of copolymer |
| 01/15/2014 | CN102516552B Degradable acid-sensitive macromolecular amphipathic cationic block copolymers and micellar particles and preparation method thereof |
| 01/15/2014 | CN102406690B Traditional Chinese medicine gynostemma pentaphylla buccal tablet |
| 01/15/2014 | CN102369253B Oil gelling agent, composition containing oil gelling agent, and external preparation or cosmetic for skin |
| 01/15/2014 | CN102367291B Mono-functional group-containing multilevel branched polyethylene glycol and synthesis method thereof |
| 01/15/2014 | CN102210630B System and method for preparing nosiheptide premix particles |
| 01/15/2014 | CN102188382B DSPE-PEG-FA-modified nanometer paclitaxel liposome and preparation method thereof |
| 01/15/2014 | CN102038715B Traditional Chinese medicine dispersible tablet and preparation method thereof |
| 01/15/2014 | CN101824083B C-terminal deletion type p43 protein and application thereof in medicaments for treating tumor |
| 01/15/2014 | CN101757609B Method for controlling residue of organic solvent in thymic peptide alpha1 microballoon |
| 01/15/2014 | CN101580547B Hasylated polypeptides, especially hasylated erythropoietin |
| 01/15/2014 | CN101559041B Polypeptide medicament sustained release microsphere or microcapsule preparation with uniform grain size and preparation method thereof |
| 01/15/2014 | CN101557828B Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease |
| 01/15/2014 | CN101524349B Phospholipids compound of bicyclo-ethanol and preparation method thereof |
| 01/14/2014 | US8629215 Malodor absorbent polymer and fiber |
| 01/14/2014 | US8628809 Method of inducing mucosal immune response to antigen with Dioscorea polysaccharides adjuvant |
| 01/14/2014 | US8628801 Pegylated nanoparticles |
| 01/14/2014 | US8628785 Method for augmenting the immunogenicity of an antigen |
| 01/14/2014 | US8628760 Personal care composition comprising a near-terminal branched compound |
| 01/14/2014 | CA2713673C Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation |
| 01/14/2014 | CA2561073C Composition and method for cancer treatment |